Upstart's Biggest Risk Isn't AI—It's Its Funding Model
Upstart gained fame for its AI-driven lending, but the real stakes for investors lie in who funds the loans. This art...
Zero Based Budgeting Process Explained
This walkthrough explains the zero-based budgeting process and how to implement it in your daily finances.
18,190 articles
Overlooked Quantum ETF Surges, Outpacing Broad Markets
A small, obscure quantum-focused ETF has vaulted in 2026, delivering outsized gains versus the S&P 500 and NASDAQ as ...
Jobs Report Released Today Sends Bond Yields Higher
The latest payroll data show a strong labor market, boosting yields and challenging expectations for quick Fed rate c...
Intel Just Experienced Monster Rally: Sell or Double Down?
After a staggering 453% surge, investors face a crossroads: take profits now or double down on a company reshaping th...
Prediction: This Artificial Intelligence Stock Could Outperform Nvidia
A bold investing idea sits beyond Nvidia: a mid-sized AI semiconductor stock poised to outrun the market over the nex...
Friday’s Market Meltdown: What Shook Bitcoin, Gold, Stocks
Friday delivered a broad, painful sell-off in crypto, gold, and stocks as robust U.S. jobs data failed to calm invest...
Jobs Beat Triggers Wiped $1.4 Trillion Market Selloff Today
A stronger-than-expected jobs report unleashed a broad market selloff, wiping $1.4 trillion from S&P 500 valuations a...
Wegovy Pill Still Dominating GLP-1 Market, Analysts Say
Wegovy continues to lead the U.S. GLP-1 market despite Eli Lilly's Foundayo launch. Investors are weighing uptake, pa...
Lightspeed Wiz’s Assaf Rappaport Bets on AI-Driven Attacker
A New York-based startup unveiled an autonomous, AI-powered offensive security platform, raising $37 million from Lig...
Applied Digital Stock Skyrocketed: What Fueled the Rally
A dramatic May rally sent applied digital stock skyrocketed as AI optimism surged. This piece breaks down the drivers...
Kyverna Therapeutics vs Vertex Pharmaceuticals: 2026 Buy Guide
In 2026, investors face a critical choice between a clinical-stage biotech and a cash-flow powerhouse. This guide com...
Wall Street Still Says Bitcoin Could Hit $100K by Year-End
Bitcoin steadied after a volatile week, with analysts debating whether the year-end target of $100,000 remains in rea...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status